Last10K.com

Merck Co., Inc. (MRK) SEC Filing 8-K Material Event for the period ending Thursday, March 7, 2019

Merck Co., Inc.

CIK: 1156831 Ticker: MRK

View differences made from one to another to evaluate Merck Co., Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Merck Co., Inc..

Continue

Assess how Merck Co., Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Merck Co., Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: MRK
CIK: 310158
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-067302
Submitted to the SEC: Thu Mar 07 2019 4:35:32 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Thursday, March 7, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mrk/0001193125-19-067302.htm